Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 3/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 5/20 | 0.44 |
| ▸ | DRD3 | P35462 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TPH1 | P17752 | 1/20 | 0.41 |
| ▸ | TPH2 | Q8IWU9 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7073119 | 0.92 | DRD4 (0.46) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL6943195 | 0.85 | GRIN1 (0.39) | GRIN2BGRIN1DRD4DRD3CYP2D6 | |
| SCHEMBL6944211 | 0.77 | DRD4 (0.36) | DRD4DRD3 | |
| SCHEMBL7075661 | 0.77 | GRIN2B (0.53) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7072578 | 0.76 | GRIN2B (0.67) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7079132 | 0.74 | GRIN2B (0.50) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7079128 | 0.74 | GRIN2B (0.50) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7676062 | 0.74 | GRIN2B (0.50) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7071755 | 0.73 | GRIN2B (0.62) | GRIN2BGRIN1GAADRD4DRD3 | |
| SCHEMBL7068562 | 0.73 | GRIN2B (0.62) | GRIN2BGRIN1GAADRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1248617-A4 | 2-AZA-BICYCLO 2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2003-03-05 | — | — | EP | claimed |
| US-6489477-B1 | NMDA NR2B ANTAGONISTS. ACCORDINGLY, ANOTHER ASPECT OF THE INVENTION IS THE TREATMENT OF PAIN, MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE--MALADIES THAT ARE AMENABLE TO AMELIORATION THROUGH | MERCK & CO., INC. | 2002-12-03 | — | — | US | claimed |
| EP-1248617-A1 | 2-AZA-BICYCLO 2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | Merck & Co., Inc. (US) | 2002-10-16 | — | — | EP | claimed |
| WO-2001032177-A1 | 2-AZA-BICYCLO[2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-10 | — | — | WO | claimed |
| EP-1248617-A4 | 2-AZA-BICYCLO 2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6489477-B1 | NMDA NR2B ANTAGONISTS. ACCORDINGLY, ANOTHER ASPECT OF THE INVENTION IS THE TREATMENT OF PAIN, MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE--MALADIES THAT ARE AMENABLE TO AMELIORATION THROUGH | MERCK & CO., INC. | 2002-12-03 | — | — | US | disclosed |
| EP-1248617-A1 | 2-AZA-BICYCLO 2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | Merck & Co., Inc. (US) | 2002-10-16 | — | — | EP | disclosed |
| WO-2001032177-A1 | 2-AZA-BICYCLO[2.2.2]OCTANE NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-10 | — | — | WO | disclosed |